News | News By Subject | News by Disease News By Date | Search News

Anti-bacterial News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
BIOCEO15: ContraFect (CFRXU) CEO Says Lysin, AB Anti-Infectives Are “Game-Changers” in 2015     2/10/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Cowen: Achaogen (AKAO)’s New Antibiotic Could Be Key to Solving Types of Drug Resistance     11/17/2014
Xellia Pharmaceuticals Expands Into The U.S. With Manufacturing Plant Buy     7/7/2014
Zurex Pharma, Inc. Nabs $4 Million to Battle Hospital-Acquired Infections     7/3/2014
Pfizer Inc. (PFE) Petitions FDA To Recall TEVA Pharmaceuticals USA (TEVA) And Sandoz, Inc. Generic Azithromycin Products To Correct Misbranding     2/9/2006
Death Reported From Sanofi-Aventis (SASY.PA) Novel Antibiotic, Ketek; Sanofi Down After FDA Alert     1/23/2006
FDA Grants Priority Review To Cubist Pharmaceuticals, Inc. (CBST) Antibiotic CUBICIN     11/21/2005
CUBICIN Meets Primary Endpoints In Ground-Breaking Staphylococcus Aureus Endocarditis/Bacteremia Study; Cubist Pharmaceuticals, Inc. (CBST) Plans To File sNDA For Expanded Label Before Year-End     6/28/2005
Pfizer Inc.'s (PFE) Single-Dose Antibiotic Zmax(TM) Receives FDA Approval     6/13/2005
MIGENIX Inc. (MGI.TO) Receives $9.3 Million Investment Commitment From Technology Partnerships Canada     4/1/2005
Vicuron Pharmaceuticals, Inc. (MICU) Provides Update On Novartis Pharma AG (NVS) Peptide Deformylase Inhibitor Program; Suspension Of Phase I First Lead Candidate In Favor Of Second Compound     3/4/2005
TaiGen Biotechnology Announces Strategic Agreement With Procter & Gamble (PG)     1/6/2005

News from Around the Web
Who Is On The WHO's New Most Dangerous Superbugs List     2/28/2017
On Point: Trends And Developments In Vascular Access Devices And Antimicrobials     10/4/2016
Could Mouthwash Fight Gonorrhea? Monash University Study     8/23/2016
A Potential Lifesaver Lies Unrecognized In The Human Body, University of Tubingen Study     7/28/2016
Travelers Could Gain Antibiotic Resistant Genes In Just Two Days, Maastricht University Study     6/28/2016
Narrow Wavelength Of UV Light Safely Kills Drug-Resistant Bacteria, Columbia University Medical Center Study Reveals     6/9/2016
Antimicrobial In Toothpaste, Soap Does Not Impact Gut, Oral Microbiome, Stanford University School of Medicine Study     5/19/2016
Plastic That Mimics Insect Wings Kills Bacteria, University of California, Irvine Study     3/16/2016
Anti-Bacterial Fabrics Show Promise Against Superbugs, Korea Institute Of Ceramic Engineering And Technology Study     3/1/2016
Common Antibiotics Can Promote C. Diff Infections By Killing Gut Bacteria, North Carolina State University Study     1/7/2016
OCT Detects, Assesses Bacterial Buildup On Medical Devices, University of California, Irvine Study     1/7/2016
CSIRO Scientists Say Pre-Historic "Goo" Could Improve Medical Devices And Implants     11/18/2015
Smart Color-Changing Medical Dressing Will Help Fight Against Antibiotic Resistance, University Of Bath Study     11/16/2015
Breast Cancer Drug Beats Superbug, University of California, San Diego (UCSD) Study     10/14/2015
McDonald's Investor Wants It To Cut Antibiotics In All Meats     9/18/2015

Press Releases
Phase II CoDIFy Trial Results Published In Lancet Infectious Diseases With Data Showing Summit Therapeutics’s Ridinilazole Achieved Statistical Superiority Over Vancomycin In The Treatment Of C. Difficile Infection     5/2/2017
AmpliPhi Bio (APHB) Announces A New Strategic Emphasis On Personalized Therapies For Serious Or Life-Threatening Antibiotic-Resistant Infections     5/1/2017
Cidara (CDTX) To Present Data On Novel Antifungal CD101 And Cloudbreak Antibacterial Immunotherapy At ECCMID And SID Annual Meetings     4/17/2017
Lakewood-Amedex Inc. Advances Novel Bisphosphocin Nu-8 Compound Based On Encouraging Pre-Clinical Results     4/4/2017
Cardiome Pharma Corp. (COM.TO) Announces Commercial Launch Of Xydalba (Dalbavancin) In France     3/3/2017
Achaogen (AKAO) Announces New Employment Inducement Grants     2/28/2017
Recce (RCE) Release: Pharma’s Lead Compound Reduces Illness In Mice Infected By Resistant E. Coli Bacteria     1/18/2017
Otonomy (OTIC) Announces Positive Top-Line Results From Phase III Clinical Trial of OTIPRIO in Patients With Acute Otitis Externa     1/5/2017
New Sensor Can Detect Bacterial Infections In 15 Minutes, The Optical Society Reveals     9/7/2016
Destiny Pharma Release: Novel Antibacterial Drug, Exeporfinium Chloride, Delivers Encouraging Safety, Tolerability And Efficacy Data In US Clinical Trial     9/6/2016
Achaogen (AKAO) Completes Patient Enrollment In Phase 3 EPIC Clinical Trial Of Plazomicin     9/1/2016
Medimetriks Pharmaceuticals, Inc.' New Drug Application For Ozenoxacin Cream, 1% Accepted For Review By FDA     8/31/2016
Elusys Therapeutics, Inc. Announces That Manuscripts For Its Anthrax Antitoxin, ANTHIM (Obiltoxaximab) Injection, Have Been Accepted For Publication     7/20/2016
Entasis Presents Data Supporting The Potential Clinical Utility Of ETX2514, A Next-generation Beta-lactamase Inhibitor, At ASM Microbe 2016     6/28/2016
Medimetriks Pharmaceuticals, Inc. Submits A New Drug Application To FDA For Ozenoxacin Cream, 1%, A Novel Impetigo Treatment     6/27/2016

//-->